An Efficacy Study of a Single Dose Treatment of PRO-513 for Subjects Suffering a Migraine Attack

This study has been completed.
Sponsor:
Information provided by:
ProEthic Pharmaceuticals
ClinicalTrials.gov Identifier:
NCT00330850
First received: May 26, 2006
Last updated: March 30, 2007
Last verified: March 2007
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: December 2006
  Estimated Primary Completion Date: No date given